You are currently viewing a new version of our website. To view the old version click .
Biomedicines
  • Correction
  • Open Access

30 April 2025

Correction: Xie et al. Exploring the Mechanisms and Preventive Strategies for the Progression from Idiopathic Pulmonary Fibrosis to Lung Cancer: Insights from Transcriptomics and Genetic Factors. Biomedicines 2024, 12, 2382

,
,
,
,
,
,
and
1
Department of Thoracic and Cardiovascular Surgery, Medical Center of Soochow University, Suzhou 215000, China
2
Department of Respiratory Medicine, Nanjing University of Chinese Medicine, Nanjing 210000, China
3
Department of Cardiothoracic Surgery, Medical School of Nanjing University, Nanjing 210002, China
4
Department of The First Clinical, Medical College of Soochow University, Suzhou 215006, China
This article belongs to the Section Cell Biology and Pathology

Error in Figure

In the original publication, there was a mistake in Figure 11 as published [1]. One of the sub-images was mistakenly used during the assembly process. Additionally, to maintain consistent height and width across the panels, some distortion of the sub-images occurred.
The corrected Figure 11 appears below. The authors state that the scientific conclusions are unaffected. This correction was approved by the Academic Editor. The original publication has also been updated.
Figure 11. MS4A4A was a potential therapeutic target for pulmonary fibrosis. (A) Tracheal MS4A4A lentivirus inhalation inhibited the relative expression of MS4A4A induced by BLM. (B,C) Tracheal inhalation of MS4A4A lentivirus inhibited the relative expression of BLM-induced fibrosis-related gene α-SMA (B) and Col1A1 (C). (D) The content of hydroxyproline in lung of MS4A4A lentivirus treated mice decreased significantly. (E) Ashcroft score analysis for evaluating fibrosis severity in mice from various groups. (F) Histological staining (HE and IHC, α-SMA, Col1A1 and MS4A4A) demonstrating that treatment with MS4A4A mitigates BLE-induced lung morphological alterations and fibrotic area expansion (scale bars: 2 mm, 50 µm and 200 µm). Abbreviations: BLM, bleomycin; HE, Hematoxylin and Eosin staining; IHC, Immunohistochemistry. Statistical significance between groups was determined using two-sided unpaired t-tests. * p < 0.05, and ** p < 0.01. Data are presented as mean ± standard error (SE). Data normality was verified with the Shapiro–Wilk test, and homogeneity of variances was confirmed using Levene’s test, with all data passing these checks.

Reference

  1. Xie, K.; Tan, X.; Chen, Z.; Yao, Y.; Luo, J.; Ma, H.; Feng, Y.; Jiang, W. Exploring the Mechanisms and Preventive Strategies for the Progression from Idiopathic Pulmonary Fibrosis to Lung Cancer: Insights from Transcriptomics and Genetic Factors. Biomedicines 2024, 12, 2382. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.